Tag: rheumatoid arthritis

Three JAK Inhibitors Get Boxed Warnings, Modified Indications

The arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR) poses an increased risk of serious cardiac events such as heart attack or stroke, cancer,...

COVID Vax Booster Trial Begun in People With Autoimmune Disease

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In the wake of the Centers for Disease Control and Prevention’s...

Study Informs About Risks of Discontinuing Meds in JIA

Many but not all children with juvenile idiopathic arthritis (JIA) can regain remission after stopping and then restarting treatment, according to preliminary data from the...

Secondhand Smoke May Raise Kids’ Rheumatoid Arthritis Risk

Aug. 23, 2021 — Did your parents light up when you were a kid? If so, you may have a higher risk of having...

Parental Smoking Linked to More Adult RA in Women

Childhood exposure to parental smoking appears to greatly boost the risk of confirmed cases of rheumatoid arthritis in adult women, although the overall rate is...

Arthritis Drug Tocilizumab Gets FDA EUA for Severe COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) issued an emergency use...

Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds

Psoriasis patients treated with biological disease-modifying antirheumatic drugs had a significantly lower incidence of psoriatic arthritis (PsA) compared with those treated with phototherapy, in a...

Secondhand Smoke Linked to Higher Arthritis Risk

June 9, 2021 — Secondhand smoke appears linked to a higher risk of rheumatoid arthritis in those who were exposed to it during childhood...

Nintedanib Slows Interstitial Lung Disease in Patients With RA

In a new subgroup analysis of a previously published multinational trial, the preservation of lung function with nintedanib (Ofev) was about the same in patients...

Gene Variant Confirmed as Strong Predictor of Lung Disease in RA

Patients with rheumatoid arthritis who carry a specific allele of the gene MUC5B have about double the risk of developing interstitial lung disease when compared...

Secondhand Smoke Linked to Higher Rheumatoid Arthritis Risk

Secondhand smoke exposure in both childhood and adulthood is associated with an increased risk of rheumatoid arthritis in women, according to a study presented at the...

Studies Highlight Pandemic’s Impact on Patients With RMDs

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Reduced access to medical care, increased mental health issues, poor lifestyle...

Many Postsurgical Hospital Readmissions Preventable

Nearly 1 in 5 postsurgical hospital readmissions are potentially preventable, and failure to prevent them costs the healthcare system almost $300 million annually, according to...

RA Experts Highlight Key Developments Over the Past Year

A massive Swedish cohort study suggesting that biologic agents reduce the known excess risk of lymphoma in patients with rheumatoid arthritis was hailed as one...

Maternal Chronic Conditions Predict Cerebral Palsy in Offspring

Several maternal chronic conditions increase the risk of giving birth to a child with cerebral palsy, based on data from more than 1.3 million Norwegian...

I Was Young and Full of Plans — RA Was a Detour I Didn’t Expect

By Andy Pendergrass As a young man graduating college and marrying the most wonderful woman I had ever met, life was good and the...

Hepatotoxicity Risk Differs Between Psoriasis, PsA, and RA Patients

Patients taking methotrexate for psoriasis or psoriatic arthritis (PsA) were at a higher risk of developing liver disease than were patients with rheumatoid arthritis (RA)...

Rheumatoid Arthritis Meds May Help Fight Severe COVID

FRIDAY, Feb. 26, 2021 (HealthDay News) — Rheumatoid arthritis drugs may save lives of patients hospitalized with severe cases of COVID-19, according to a groundbreaking...

Tocilizumab May Improve Lung Function in Early Systemic Sclerosis

Treatment with tocilizumab (Actemra) could stabilize or improve lung function in people with early interstitial lung disease associated with systemic sclerosis (SSc-ILD), a new study...

Tofacitinib Linked to Risk for Cardiac Events, Cancer, FDA Warns

The Food and Drug Administration has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase...

Patients With Early Arthritis May Need Tailored Treatments

Patients with early, undifferentiated arthritis may benefit from milder or stronger treatments, depending on the number of their risk factors for developing rheumatoid arthritis, researchers...

Tofacitinib for RA Misses the Mark in Safety Study

Daily treatment with tofacitinib (Xeljanz) led to more malignancies and adverse cardiovascular events in older rheumatoid arthritis patients compared with treatment with a tumor necrosis...

Tough Pain Relief Choices in the COVID-19 Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. More people with fever and body aches are turning to nonsteroidal...

Denosumab Promising for Osteolysis After Total Hip Replacement

NEW YORK (Reuters Health) – Denosumab showed biological efficacy against osteolysis after total hip replacement in a proof-of-concept trial. “Denosumab is already a well-established licensed...

The Link Between Chronic Inflammation and RA

Medication. Nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, and biologic agents can ease inflammation and pain and slow joint damage. Your rheumatologist will recommend the...